To the Editor:
The homeostasis of the epidermis is regulated by a multitude of factors that act via speci®c receptors on the keratinocyte surface. These factors are normally released in a paracrine or autocrine way. There is a rare condition, however, in which epidermal growth is thought to be regulated by an endocrine mechanism, i.e., by growth factors synthesized in tissues other than the skin and released into the circulation: paraneoplastic or malignant acanthosis nigricans (MAN).
The pathogenesis of MAN is still unclear. A current hypothetical mechanism is the secretion of large amounts of transforming growth factor a (TGF-a) by the tumor into the circulation that is thought to stimulate keratinocyte growth via an endocrine route (Koyama et al, 1997) . Increased production of TGF-a has been found in the vast majority of primary bladder carcinomas and in cells isolated from such tumors (Mellon et al, 1996; Gazzaniga et al, 1998; Ruck and Paulie, 1998; Tungekar and Linehan, 1998) , and there seems to be a positive correlation between tumor stage and expression levels of this growth factor (Ravery et al, 1997; Kee et al, 2001) .
TGF-a is a primary mediator of benign and malignant keratinocyte hyperproliferation in vivo: upregulation of TGF-a production and epidermal growth factor receptor (EGFR) expression have been found in samples of psoriatic human skin (Nanney et al, 1986; Elder et al, 1989) and in squamous cell carcinomas (Donnelly et al, 1993; Jones et al, 1993) . When overexpressed in the epidermis of transgenic mice TGF-a induces epidermal thickening caused by keratinocyte hyperproliferation (Vassar and Fuchs, 1991) .
TGF-a is closely related to epidermal growth factor (EGF) and binds to the same receptor, EGFR (Kramer et al, 1994) . This binding induces activation of the classical mitogen-activated protein kinase (MAPK, ERK) pathway, a module of three protein kinases that is organized in a hierarchical fashion and is known to regulate basic cellular functions such as proliferation, differentiation, and migration (Marshall, 1994) . Our previous studies of ERK activation in primary human keratinocytes have revealed a role for this pathway in the regulation of keratinocyte proliferation and differentiation: sustained activity of ERK suppresses and ERK inhibition induces differentiation (Haase et al, 2001) . Given the role of ERK in the development of hyperproliferative skin lesions we asked whether alterations of ERK activity would play a role in the pathogenesis of MAN.
Biopsies were taken after obtaining informed consent from a patient suffering from MAN associated with metastatic bladder carcinoma. The MAN lesions were most pronounced at areas of corni®ed epithelium bordering the mucosa of lips and eyelids. Investigations were carried out in samples from the lip of this patient and in samples of normal skin and normal buccal mucosa obtained from different individuals. In normal skin and normal mucosa EGFR is constitutively expressed in the basal keratinocyte layer and variably in the ®rst and second suprabasal keratinocyte layer (Fig 1a and data not shown) . This expression pattern was altered dramatically in MAN skin: EGFR was present on the cell surface of basal and most suprabasal keratinocytes (Fig 1b, c) . Assessment of cell proliferation using immunostaining against Ki67 and PCNA showed increased proliferation of basal but not suprabasal keratinocytes in MAN skin (data not shown). These changes were accompanied by dramatic alterations in the expression of keratin 14 (K14), were stained with a monoclonal antibody against EGFR (green staining in a±c; Santa Cruz Biotechnology) or a monoclonal antibody against human keratin 14 (green in d, e; Progen, Heidelberg, Germany). Nuclei are shown in red. Magni®cations are the same for a, c, e, and d; b shows an overview of MAN skin stained for EGFR at a lower magni®cation. The DNA dye ToProIII and secondary antibodies coupled to the¯uorescent dye Alexa 488 (Molecular Probes, Eugene) were used to visualize nuclei and detected proteins; images were taken using a Leica TCS upright confocal laser scanning microscope at excitation wavelengths of 488 and 633 nm. Scale bars: b, 500 mM, e, 200 mM.
which is normally con®ned to basal keratinocytes (Fig 1d, e) . In MAN lesions K14 was present in all viable, i.e., basal and suprabasal keratinocytes. Similar changes in keratin expression have also been found in other hyperproliferative skin conditions (Wongwaisayawan et al, 1991) and indicate a delayed onset of terminal differentiation.
Using a combination of Western blotting and confocal laser scanning microscopy with antibodies that detect phosphorylationspeci®c epitopes of ERK we analyzed activation of MAPK signaling in normal skin and mucosa and in MAN lesions. Western blot analysis of two samples from normal skin and one sample from MAN skin showed a dramatic increase in the proportion of phosphorylated, i.e., activated, ERK2 in MAN skin (Fig 2e and data not shown) . This activation was speci®c for ERK as jun-N terminal kinase (JNK) whose activity is also regulated by EGFR-dependent signaling (Hashimoto et al, 1999) showed no signi®cant increase in phosphorylation in the same sample (Fig 2e) . We then used the phosphorylation-speci®c antibody to localize ERK activity in cryostate sections of MAN skin and control samples. As reported previously (Haase et al, 2001) , incubation of sections of three different samples of normal skin and one sample of normal buccal mucosa with the antibody against activated ERK did not yield any staining above background levels (Fig 2c, d , and data not shown). In contrast, sections of MAN skin showed focal staining of nuclei of keratinocytes but not stromal cells (Fig 2a, b) . Keratinocytes in proximity to the stromal parts of the MAN lesion exhibited most pronounced ERK activation. In  Fig 2(b) , which is the same section as in Fig 2(a) , nuclei were visualized using a¯uorescent nuclear dye, ToProIII (red staining). The overlap of the green staining for phosphorylated ERK and the red nuclear staining results in a yellow signal for nuclei containing activated ERK (Fig 2b) .
Binding of TGF-a to EGFR leads to the stimulation of ERK in many systems (see, for example, Oliver et al, 1995).
Our Western blot analysis clearly shows that levels of total ERK activity were indeed elevated in MAN skin (Fig 2e) . The ®nding that activated ERK was not only present in the basal compartment but also in suprabasal cells within the lesion suggests that EGFR expressed suprabasally is functional. In this context it appears interesting that, in spite of increased ERK activity in basal and suprabasal cells, proliferation was restricted to basal keratinocytes. This is consistent with in vitro ®ndings demonstrating that ERK activation is not suf®cient to stimulate anchorage-independent growth in primary human keratinocytes (Haase et al, 2001) and suggests that additional, probably adhesion-dependent, factors are required in order to translate the growth stimulating effect of ERK activity. The distribution of activated ERK within the MAN lesion also raises the question of which function this pathway exerts in suprabasal keratinocytes. We have shown recently that, though ERK activation is not suf®cient to stimulate proliferation of suspended keratinocytes, it can delay the program of terminal differentiation (Haase et al, 2001) . In agreement with that we found dramatic alterations in the expression of keratin 14 in MAN skin.
A disturbed balance between proliferation and differentiation of epidermal keratinocytes is a feature of several skin diseases and we are only just beginning to understand the intracellular signaling pathways involved. There is now accumulating evidence for a role of ERK activation in epidermal hyperproliferation (Albanell et al, 2001; Haase et al, 2001 ). Here we demonstrate activation of ERK signaling in a case of MAN and provide further evidence for a pathogenic role of this pathway in hyperproliferative skin disease.
Ingo Haase, Nicolas Hunzelmann University of Cologne, Center of Molecular Medicine and Department of Dermatology, University of Cologne, Germany Photocarcinogenesis is a complex process comprising the induction of mutations in cellular DNA by exposure of the skin to ultraviolet (UV) radiation, the failure of the nucleotide excision repair system to completely restore the integrity of the genome, and the concurrent modulation of the cutaneous immune system. The two important chromophores for UV radiation in the epidermis are urocanic acid (UCA) and DNA, both considered to be involved in photocarcinogenesis. Downregulation of the immune system by DNA damage (Vink et al, 1997) or cis-urocanic acid (cis-UCA) (Noonan and De Fabo, 1992) , the immediate photoisomerization product of the endogenous trans-UCA, may contribute to the growth of highly antigenic, UV-induced skin cancers. The formation and repair of DNA photoproducts as well as the cutaneous concentration levels of UCA share one interesting feature in common; they show signi®cant interindividual variation (Snellman et al, 1997; Bykov et al, 1998 ). High formation rates or defective repair of DNA photoproducts in the skin of an individual with high (cis-)UCA levels would pose an increased risk of UV tumors. Data on such a possibility are not currently available. We have compared the induction and repair of DNA photoproducts and UCA production in the Caucasian skin. The study was compiled from available data of a total of 17 volunteering subjects (eight females and nine males) who had earlier been assessed both for photoisomerization of UCA (Snellman et al, 1999) and for the formation of DNA photoproducts in situ (Xu et al, 2000a,b,c) . Eight of the subjects were previously treated for cutaneous malignant melanoma (CMM), four for basal cell carcinoma (BCC), and ®ve were healthy controls ( Table I) . UV irradiation was performed with a spectroradiometrically calibrated solar-simulating UV lamp Philips HP411/A speci®ed recently (Snellman et al, 1997 (Snellman et al, , 1999 Xu et al, 2000a,b,c) . UCA was sampled both from the protected and UV-exposed [only 10 J per m 2 CIE 2 (Commission Internationale de l'E Â clairage; McKinlay and Diffey, 1987) erythemally weighted irradiation dose to avoid the photostationary state be reached] back skin using the Finn Chamberâ epidermal sampling (Jansen et al, 1991) . The formation of cyclobutane pyrimidine dimers (CPD) and 6±4 photoproducts in situ were assessed after an erythemally weighted dose of 400 J per m 2 CIE 2. This was the highest minimal erythema dose detected in our probands and high enough for the follow-up of repair rates of UV photoproducts. Skin biopsies were taken immediately and 24 h after the exposure and analyzed with the 32 P-postlabeling technique (Bykov and Hemminki, 1995; Bykov et al, 1999) .
The levels of photoproducts measured immediately after irradiation showed wide interindividual differences, as did the UCA levels ( Table I) . CPD and 6±4 photoproducts were formed with different ef®cacy, the 6±4 photoproduct levels (TT-T and TT-C) being 15%±17% of those of CPD, conforming with results of a larger series (Xu et al, 2000c) . A new ®nding, which needs to be con®rmed in future studies, was that the total UCA concentration rose in 16 of 17 subjects after UV exposure. This phenomenon may be a result of a rapid induction of the histidase enzyme either by the alkaline sampling conditions (Jansen et al, 1991) or by the used irradiation type and dose, a combination of the two, or it may re¯ect an acute irradiation-induced change in the epidermal environment to allow increased diffusion of UCA into the sampling chambers. We calculated the Pearson's correlation coef®cients for epidermal total UCA or cis-UCA levels and DNA photoproducts. Con®dence intervals for correlation were deter- 
